BioHealth MultiVitamin & Mineral for Women Tablet
BioHealth MultiVitamin & Mineral for Women Tablet, NPN 80020398: natural health product licensed in Canada. Medicinal ingredients: Riboflavine, Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid, Cuivre, Chrome.
If this product were sold in France
- Declared dose above a limit
Chrome: up to 35 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Declared dose above a limit
Sélénium: up to 55 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Declared dose above a limit
Manganèse: up to 5 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Riboflavine | 2.5 mg | 2,500 µg |
| Hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanoic acid | 45 mcg | Not calculated |
| Cuivre Source : Copper HVP chelate | 1,000 mcg | 1,000 µg |
| Chrome Source : Produit de chélation de chrome et de PVH | 35 mcg | 35 µg |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 55 mcg | 55 µg |
| Potassium Source : Chlorure de potassium | 80 mg | 80,000 µg |
| Vitamine C Source : 2-O-glucoside de l'acide ascorbique | 90 mg | 90,000 µg |
| psi,psi-carotène Source : Lycopène | 600 mcg | Not calculated |
| Manganèse Source : Sulfate de manganèse (II) | 5 mg | 5,000 µg |
| Molybdène Source : Citrate de molybdène | 45 mcg | 45 µg |
| Vitamine A Source : Palmitate de vitamine A Potency : 1,000 UI | 300 mcg EAR | Not calculated |
| Magnésium Source : Oxyde de magnésium | 55 mg | 55,000 µg |
| Magnésium Source : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH) | 55 mg | 55,000 µg |
| Folate | 1,000 mcg | Not calculated |
| 2-hydroxy-N,N,N-triméthyléthanaminium Source : Bitartrate de choline | 5 mg | Not calculated |
| Vitamine B12 Source : Cyanocobalamine | 20 mcg | 20 µg |
| Vitamine E Source : Acétate de d-alpha-tocophéryle Potency : 50 UI | 33.5 mg AT | Not calculated |
Non-medicinal ingredients
Silica, Magnesium stearate, Cellulose, Dicalcium Phosphate
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adults | Not specified | 1 tablet | 1 daily |
Uses authorised in Canada
A factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Keep out of reach of children. There is enough drug in this package to seriously harm a child.
- Known Adverse Reactions
People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Product record
- Other names
- Good Life MultiVitamin & Mineral for Women Tablet, MultiVitamin & Mineral for Women Tablet
- Licence holder
- BioHealth Labs Inc.
- NPN or DIN-HM
- 80020398
- Status
- Active licence
- Licence date
- 29 June 2010
- Revision date
- Not provided
- Form
- Tablet
- Route of administration
- Oral
- Application type
- Compendial
Source
Official Health Canada record, licence 80020398
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BioHealth MultiVitamin & Mineral for Women Tablet (BioHealth Labs Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80020398-biohealth-multivitamin-mineral-for-women-tablet, updated 29 June 2010.